Physician
Mohrokh Hedayati, M.D., P.A
Mohrokh Hedayati, M.D., P.A was paid $1.85M by Medicaid between Jul 2020 and Dec 2024, across 65 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 24% of everything it billed.
33Billing provider infoMOHROKH HEDAYATI, M.D., P.A
ROCKWALL, TX 75032
ROCKWALL, TX 75032
33aNPI1841449535assigned 09/17/2008
33bProvider typePediatrics Physician
28Total paid$1.85M
24GClaims71,909
24DCodes billed65
24AFirst – last monthJul 2020 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#259 of 1,136
Median peer was paid$329K
This provider vs. median5.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 433 | $16K | |
| 2021 | 16,527 | $382K | |
| 2022 | 19,255 | $477K | |
| 2023 | 18,530 | $494K | |
| 2024incomplete | 17,164 | $485K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 24% | 8,744 | 7,950 | $441K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 11,169 | 10,024 | $405K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 10% | 2,589 | 2,517 | $189K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 9.4% | 2,642 | 2,409 | $175K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.8% | 1,548 | 1,540 | $125K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.9% | 10,993 | 4,525 | $110K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.4% | 942 | 934 | $81K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 2.6% | 1,283 | 1,238 | $47K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.0% | 2,872 | 2,786 | $38K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.0% | 2,646 | 1,291 | $37K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.8% | 4,564 | 3,973 | $33K |
| 99381 | 1.6% | 472 | 447 | $30K |
53 more codes
| 99383 | 1.4% | 316 | $26K | |
| 99203 | Doctor's office visit, new patient (routine) | 1.4% | 492 | $25K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 1,647 | $22K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 203 | $15K |
| 90461 | <1% | 3,972 | $14K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 515 | $6K |
| 99382 | <1% | 71 | $5K | |
| 87807 | <1% | 402 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 156 | $4K |
| 99384 | <1% | 45 | $4K | |
| 99000 | <1% | 412 | $3K | |
| 93000 | <1% | 255 | $3K | |
| Q3014 | Telehealth originating site facility fee | <1% | 122 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 171 | $2K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 15 | $1K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 101 | $801.06 |
| 92551 | <1% | 61 | $579.38 | |
| 99050 | <1% | 45 | $523.60 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 380 | $262.23 |
| 96127 | <1% | 994 | $249.20 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 16 | $230.88 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 27 | $181.82 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 402 | $121.18 |
| 81003 | <1% | 53 | $86.94 | |
| 90473 | <1% | 75 | $72.61 | |
| 83655 | <1% | 183 | $50.85 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 45 | $37.63 |
| 94664 | <1% | 72 | $26.25 | |
| 99080 | <1% | 32 | $25.00 | |
| 81000 | <1% | 26 | $13.52 | |
| 94760 | <1% | 18 | $1.96 | |
| 90670 | <1% | 1,543 | $0.03 | |
| 90648 | <1% | 1,348 | $0.03 | |
| 90723 | <1% | 958 | $0.02 | |
| 90681 | <1% | 791 | $0.01 | |
| 90710 | 0% | 348 | $0.00 | |
| 90715 | 0% | 150 | $0.00 | |
| 99173 | 0% | 403 | $0.00 | |
| 90700 | 0% | 236 | $0.00 | |
| 85014 | 0% | 97 | $0.00 | |
| 90633 | 0% | 1,084 | $0.00 | |
| 90734 | 0% | 166 | $0.00 | |
| 90707 | 0% | 324 | $0.00 | |
| 84030 | 0% | 12 | $0.00 | |
| 90698 | 0% | 369 | $0.00 | |
| 90716 | 0% | 346 | $0.00 | |
| 85018 | 0% | 97 | $0.00 | |
| 90677 | 0% | 402 | $0.00 | |
| 36416 | 0% | 765 | $0.00 | |
| 90696 | 0% | 249 | $0.00 | |
| 90686 | 0% | 335 | $0.00 | |
| 90619 | 0% | 25 | $0.00 | |
| 90656 | 0% | 73 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHENISEY, ABBY (PRACTICE ADMINISTRATOR)